Gufic Biosciences Limited — Board Meeting, 29-05-2026: Outcome of Board Meeting
29-05-2026 | 10:13 pm
29-05-2026 | 10:13 pm
Gufic Biosciences approved Q4 & FY26 consolidated results: Revenue Rs 944.01 Cr, Net Profit Rs 64.21 Cr. The Board proposed a Re. 0.10/share dividend and approved a Rs 5.75 Cr investment in Saraswat Co-operative Bank.
No comments yet. Be the first to comment!
